The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...

Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic ...

The treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for patients ...

According to Governor Glenn Youngkin's executive order, it is up to individual school boards to be clear on their protocol.

Manassas students will return from winter break with new rules on cellphones after the Manassas School Board approved changes ...

Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...

Epcoritamab-bysp showed a 69% objective response rate and 62% complete response rate in older patients with large B-cell ...

Molicel, a global leader in ultra-high power cells, has achieved a significant milestone by securing the prestigious AS9100:D ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may ...

FDA approved for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma that is not ...

Research presented at ASH 2024 has shed new light on treatment strategies for mantle cell lymphoma and follicular lymphoma.